Camilla Soenderby

Director/Board Member at BB BIOTECH AG

Net worth: - $ as of 2026-06-29

Health Technology

Distribution Services

Finance

Profile

Ms. Camilla Soenderby is an Independent Director at Inventiva SA and an Independent Director at Abivax SA. She is on the Board of Directors at Inventiva SA, Abivax SA, BB Biotech AG, F2G Ltd. and Affibody Medical AB. Ms. Soenderby was previously employed as a Head-Product Strategy Officer by Takeda Pharmaceutical Co., Ltd., a Head-Global Product Strategy by Shire France SAS, a General Manager by AbbVie SAS (France), and a General Manager by Schering-Plough Ltd. (Taiwan).
She received her undergraduate degree from the University of Copenhagen.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ABIVAX SA -.--%	2026-02-27	0 ( -.--% )	- $	2026-06-29

Camilla Soenderby active positions

Companies	Position	Start
BB BIOTECH AG	Director/Board Member	2024-03-20
ABIVAX	Director/Board Member	2024-04-01
INVENTIVA	Director/Board Member	2026-06-29
F2G Ltd. F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment	Director/Board Member	2021-09-14
Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services	Director/Board Member	-

All active positions of Camilla Soenderby

Former positions of Camilla Soenderby

Companies	Position	End
TAKEDA PHARMACEUTICAL COMPANY LIMITED	Corporate Officer/Principal	2019-12-31
Schering-Plough Ltd. (Taiwan) Schering-Plough Ltd. (Taiwan) Medical DistributorsDistribution Services Sells and supplies pharmaceutical products	Corporate Officer/Principal	-
AbbVie SAS (France) AbbVie SAS (France) Medical DistributorsDistribution Services Engages in wholesale distribution of prescription drugs and proprietary drugs	Corporate Officer/Principal	-
Shire France SAS Shire France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Corporate Officer/Principal	-

See the detail of Camilla Soenderby's experience

Training of Camilla Soenderby

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Camilla Soenderby's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
BB Biotech AG BB Biotech AG Financial ConglomeratesFinance Provides investment services for biotechnology sector	Finance
Takeda Pharmaceutical Co., Ltd. Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products	Health Technology
Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services	Health Technology
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
F2G Ltd. F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment	Health Technology
Shire France SAS Shire France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Abivax SA Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms	Health Technology
Inventiva SA Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases	Health Technology
Schering-Plough Ltd. (Taiwan) Schering-Plough Ltd. (Taiwan) Medical DistributorsDistribution Services Sells and supplies pharmaceutical products	Distribution Services
AbbVie SAS (France) AbbVie SAS (France) Medical DistributorsDistribution Services Engages in wholesale distribution of prescription drugs and proprietary drugs	Distribution Services